Thymus involvement in early-onset myasthenia gravis

Area of Science:

• Immunology
• Endocrinology
• Pathology

Background:

• The thymus is central to autoimmune myasthenia gravis (MG), linked to thymoma or thymic hyperplasia.
• Hyperplastic MG thymus exhibits characteristics of tertiary lymphoid organs (TLOs).

Purpose of the Study:

• To review thymic changes in hyperplasia and their role in autoimmune responses against acetylcholine receptors (AChRs).
• To explore the role of interferon-beta (IFN-β) in MG thymus pathogenesis.

Main Methods:

• Review of existing literature on thymic changes in MG.
• Analysis of TLO characteristics in hyperplastic MG thymus.

Main Results:

• MG thymus displays TLO features: neoangiogenesis, chemokine overexpression, and ectopic germinal centers.
• AChR expression on thymic cells facilitates antigen presentation to recruited immune cells.
• Interferon-beta (IFN-β) is overexpressed and may orchestrate thymic changes.

Conclusions:

• Thymic hyperplasia in MG transforms the thymus into a TLO, driving autoimmunity.
• Local inflammation, potentially orchestrated by IFN-β, is crucial for this transformation.
• Further research into IFN-β induction and persistence is needed to understand MG etiology and pathophysiology.